Ignite Creation Date:
2024-05-06 @ 2:48 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02135315
Status:
COMPLETED
Last Update Posted:
2022-08-24
First Post:
2014-03-27
Brief Title:
Intensive Arterial Pressure Control in Acute Coronary Syndrome
Sponsor:
University of Monastir
Organization:
University of Monastir
Study Overview
Official Title:
One-year Outcome of Intensive Versus Standard Blood Pressure Treatment in Non-ST Elevation Acute Coronary Syndrome A Randomised Controlled Trial
Status:
COMPLETED
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IAPREC
Brief Summary:
The intensive arterial pressure control in acute coronary syndrome ACS during the first 24 hours can improve the prognosis in the short and long term
the study compare two treatment strategies standard and intensive treatment to assess their efficacy and safety in the treatment of acute coronary syndrome
the study compare two treatment strategies standard and intensive treatment to assess their efficacy and safety in the treatment of acute coronary syndrome
Detailed Description:
Acute coronary syndrome is often associated with arterial pressure elevation which are deleterious for the heart and needs urgent intervention to lower the blood pressure to the required values however there is no clear recommendations concerning the treatment intensity in this situation
The investigators know that high arterial pressure increases the oxygen myocardial consumption and it is deleterious in acute coronary syndrome so it is logical to reduce intensively this pressure
The investigators know that high arterial pressure increases the oxygen myocardial consumption and it is deleterious in acute coronary syndrome so it is logical to reduce intensively this pressure
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None